Worldwide, there are different screening protocols for CF, all implying a first dosage of immunoreactive trypsinogen (IRT) on a newborn blood spot, then variably linked to an IRT repeat measurement, a CFTR mutations analysis, pancreatitis associated protein (PAP) evaluation and sweat test for chloride concentration [66,67]. This evidence concerns the gene CFTR and cystic fibrosis.